Zhang Tingxiu, Hu Sheng, Teng Yue, Li Zhiwei, Xiao Zhenliang, Ma Lijie
Department of Pulmonary and Critical Care Medicine Chinese People's Liberation Army Western Theater General Hospital Chengdu Sichuan China.
Clin Case Rep. 2024 Aug 19;12(8):e9342. doi: 10.1002/ccr3.9342. eCollection 2024 Aug.
A comprehensive diagnostic approach, including immunohistochemistry, is crucial for confirming pulmonary Langerhans cell histiocytosis in adults. Individualized treatment with dynamically adjusted chemotherapy based on therapeutic response leads to significant absorption of lesions and symptom alleviation. Regular follow-up and timely treatment adjustments according to the patient's condition are essential in managing this rare disease.
包括免疫组织化学在内的综合诊断方法对于确诊成人肺朗格汉斯细胞组织细胞增多症至关重要。基于治疗反应动态调整化疗方案的个体化治疗可使病灶显著吸收并缓解症状。对于这种罕见疾病的管理,定期随访并根据患者病情及时调整治疗至关重要。